CME sues CFTC over crypto perp classification as futures instead of swaps
CME Group is suing the CFTC to force crypto perpetual futures into stricter swap regulation while publicly arguing its institutional clients do not demand them, a contradiction that exposes a turf war over market classification and who controls next-generation derivatives trading. The outcome will determine whether perps trade under futures or swap rules, reshaping custody, leverage, and tax treatment for U.S. crypto traders.
- CME filed a June 18 complaint arguing perps are swaps because funding rate payments meet the CEA’s swap definition, lacking futures’ defining fixed expiration date.
- CEO Terry Duffy said on a July earnings call that 94% of CME volume comes from institutional traders who are not requesting perps, positioning them as a retail product.
- CFTC approved Kalshi’s Bitcoin perp as a futures contract on May 29 and argued in a September motion that CME lacks legal standing to sue because it can list perps itself.
- May 29 CFTC approved Kalshi’s Bitcoin perpetual futures contract
- 94% CME’s institutional trader volume in first half of 2026, versus retail trader share
- 250x Maximum leverage available on some offshore perps, by Duffy’s observation versus regulated alternatives
CME Group filed a complaint in U.S. District Court on June 18 challenging the CFTC’s May 29 approval of Kalshi’s Bitcoin perpetual futures contract. The exchange argues that perpetual futures, contracts with no expiration date that allow indefinite leveraged positions, fit the statutory definition of swaps under the Commodity Exchange Act, not futures. CME contends that funding rate payments, the periodic transfers between long and short positions that keep a perp tracking spot price, fit the definition of a swap and thus should trigger swap regulation under Dodd-Frank.
The CFTC took the opposite view when it approved Kalshi’s perp as a futures contract, opening the door for other exchanges to list perps under futures rules. On September 2, the regulator filed a motion to dismiss CME’s lawsuit on standing grounds, arguing CME has no right to sue because it is already a registered exchange and could list the same contracts itself if market demand warranted.
Institutional focus contradicts CME’s swap-classification lawsuit
CME CEO Terry Duffy’s public statements underscore the tension in the company’s legal position. According to a July earnings call, Duffy said CME saw 94% of its volumes from institutional traders in the first half of 2026 and said customers were not asking for perps.
Yet in the lawsuit, CME simultaneously claims Kalshi’s perps target retail investors who also use CME’s products, framing the CFTC’s approval as a competitive threat. This framing sidesteps Duffy’s own assertion that institutional traders, CME’s core base, are not requesting perps.
The contradiction suggests CME’s regulatory posture aims less at protecting its current client base than at preventing rivals from capturing the retail perp market under a favorable classification.
Swap versus futures status reshapes collateral, leverage and tax treatment
The classification dispute carries material consequences. Under swap regulation, customer funds receive different segregation and bankruptcy protection than futures collateral. Futures enjoy standardized tax treatment under Section 1256, allowing traders to use 60/40 long-term/short-term gains classification regardless of holding period; swap tax status remains unsettled.
Leverage caps also differ: futures markets use conventional margin rules, while swap regulation historically allowed participants greater discretion in leverage design.
Duffy flagged a specific concern about offshore perps running 250x leverage, contrasting that with Kalshi’s stated cap of roughly six times leverage. He dismissed industry promises to self-impose leverage limits without formal rulemaking to enforce them.
If perps are classified as futures, the CFTC could impose standardized leverage caps; as swaps, leverage would depend on swap dealer discretion and counterparty agreements, creating inconsistency across platforms.
Standing dismissal could leave classification unresolved indefinitely
The CFTC’s September motion argues CME lacks standing because any registered exchange, including CME itself, may now list perps under futures status pending court review. A dismissal on standing grounds would terminate the lawsuit without deciding the fundamental CEA question: whether funding rate payments satisfy the swap definition.
That outcome would leave a market governed by a regulatory classification no court has adjudicated, allowing multiple exchanges to list perps as futures while the legal theory remains contested.
Kalshi CEO Tarek Mansour countered that perps offer leverage comparable to traditional futures and target disciplined traders, not explosive retail speculation.
The CCS read. We read this as a dispute over distribution rights dressed as statutory interpretation. CME controls the institutional derivatives market and is fighting to keep retail perps confined to either swap dealer regulation (which CME operates) or off-exchange venues where it faces no listed-exchange competition. If the court denies CME standing, retail perps trade as futures indefinitely without judicial endorsement of that classification, benefiting Kalshi and any new exchange entrant while CME’s leverage complaint goes unheard.
No ruling has yet been reported. The court’s response to CFTC’s standing motion, expected within weeks, will determine whether the case proceeds to a merits hearing on the perp classification question or terminates without resolving whether funding rates constitute swap payments under Dodd-Frank. Duffy’s next public move will signal whether CME intends to launch its own perps if the lawsuit fails and the futures classification becomes settled law.